Long-term efficacy and safety of continued complement C1s inhibition with sutimlimab in cold agglutinin disease: CADENZA study Part B.
Röth A, Berentsen S, Barcellini W, D'Sa S, Jilma B, Michel M, Weitz IC, Yamaguchi M, Nishimura JI, Vos JMI, Cid J, Storek M, Wong N, Yoo R, Jayawardene D, Srivastava S, Wardęcki M, Shafer F, Lee M, Broome CM.
Röth A, et al. Among authors: yoo r.
EClinicalMedicine. 2024 Jul 18;74:102733. doi: 10.1016/j.eclinm.2024.102733. eCollection 2024 Aug.
EClinicalMedicine. 2024.
PMID: 39091672
Free PMC article.